Topics

AbbVie set to receive $330m after exiting Reata deal: http://bit.ly/2B2Wzli pic.twitter.com/MZOjN7u6FB

14:00 EDT 11 Oct 2019 | Pharmafile

AbbVie set to receive $330m after exiting Reata deal: http://bit.ly/2B2Wzli 

Original Article: AbbVie set to receive $330m after exiting Reata deal: http://bit.ly/2B2Wzli pic.twitter.com/MZOjN7u6FB

NEXT ARTICLE

More From BioPortfolio on "AbbVie set to receive $330m after exiting Reata deal: http://bit.ly/2B2Wzli pic.twitter.com/MZOjN7u6FB"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...